Picture of Essex Bio-Technology logo

1061 — Essex Bio-Technology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Brief: Essex Bio-Technology Says Unit Agreed To Subscribe For Subscription Shares Of Antikor

July 19 (Reuters) - Essex Bio-Technology Ltd  1061.HK :
    * ESSEX BIO-INVESTMENT AGREED TO SUBSCRIBE FOR SUBSCRIPTION
SHARES
OF ANTIKOR AT AGGREGATE CONSIDERATION OF UP TO US$3.1 MILLION
    * ESSEX BIO-INVESTMENT AND ANTIKOR BIOPHARMA  WILL ENTER
INTO IP
LICENCE AGREEMENT

Source text for Eikon:  ID:nHKS9MGMTJ 
Further company coverage:  1061.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Essex Bio-Technology

See all news